Methods US Adults Used to Stop Smoking, 2021–2022

Introduction

Although considerable progress has been made in the last decade in the US to reduce prevalence of combustible cigarette smoking [1], smoking continues as one of the leading causes of chronic disease [2]. Thus, further reductions in smoking prevalence are crucial to preventing or reducing the effects of chronic disease in the US. A previous study identified giving up cigarettes all at once, gradually cutting back on cigarettes, and substituting some cigarettes with e-cigarettes as the most commonly reported stop-smoking methods during quit attempts from 2014 through 2016 [3]. More recent data are needed to understand who stopped smoking since 2016 and how they did it. The objectives of this study were to identify which subpopulations stopped smoking completely (reported having stopped smoking for ≥6 months in the past year as defined in previous research [4]) or tried to stop smoking, and to quantify the methods they used by using the most recent CDC National Health Interview Survey (NHIS) data [5].

Methods

Data on methods used to stop smoking were sourced from CDC’s latest NHIS. These data are nationally representative and have low bias [5]. The 2022 NHIS (fielded January–December 2022) asked respondents who had stopped smoking in the past 2 years which methods they used to stop smoking completely. These analyses focused on those respondents who had stopped smoking in the last year (2021 through 2022) and who had stopped smoking for 6 months or longer at the time of the survey. The survey also asked respondents who were still smoking but had tried to stop in the past year which methods they used when they tried. Full details of questionnaire wording are available in online supplemental materials (https://doi.org/10.17605/osf.io/HGMN6). The prevalence of each stop-smoking method was calculated with NHIS sampling weights to provide nationally representative population estimates. NHIS stratum and cluster variables were also used to provide 95% CIs. Demographic characteristics of the sample of adults who stopped smoking or tried to stop (sex, race or ethnicity, age, education, and sexual orientation) were derived from standard NHIS questions, similar to other CDC NHIS publications [6, 7].

Only publicly available, de-identified survey data were used; therefore, this study is exempt from NIH human subjects research under NIH exemption 4 and did not require institutional review board review.

Results

Overall, 2.9 million US adults stopped smoking from 2021 through 2022 and had been stopped for 6 months or longer at the time of the survey. In the same period, 13.1 million tried to stop but were unsuccessful. Slightly more men stopped smoking than women (1.6 million vs 1.3 million); most were non-Hispanic White adults, most were aged younger than 55 years, most had at least some college education, and most self-identified as straight (Table 1). Among those who stopped smoking for 6 months or longer, the most commonly reported methods used were nicotine products (53.9%, 1.5 million US adults), primarily e-cigarettes used alone or in combination with other methods (40.8%, 1.2 million US adults; Table 2). The least commonly reported methods were non-nicotine, non-prescription drug methods (including a quit line, counseling or clinic, class, or group) (6.3%, 0.2 million US adults). Of the listed methods, the most commonly reported exclusive method selected was e-cigarettes; 26.0% (0.7 million US adults) of adults who stopped smoking from 2021 through 2022 for 6 months or longer selected e-cigarettes as their only listed method.

Discussion

This study identified subpopulations of US adults in NHIS 2022 who stopped or tried to stop smoking and the methods they used. Results showed that smaller proportions of all adults who stopped smoking from 2021 through 2022 were women, Hispanic and non-Hispanic non-White, older (aged ≥55 y), had lower educational attainment (less than some college education), and were non-heterosexual. This may be explained simply by relative subpopulation size (i.e., the US adult population comprises fewer non-heterosexual adults compared to heterosexual adults and more males who smoke than females [8]). Nevertheless, it is important to ensure that specific subpopulations do not get left behind in efforts to curb smoking.

Approximately 40% of adults surveyed in NHIS did not report using any of the surveyed evidence-based methods to stop smoking. Methods containing nicotine, primarily e-cigarettes, were the most commonly-reported methods that were explicitly surveyed. This may provide support for FDA’s “nicotine-focused framework for public health” [9], which describes noncombustible nicotine products as “a promising foundation for a comprehensive approach to tobacco harm reduction,” FDA’s efforts to authorize certain e-cigarette products as “appropriate for the protection of public health” [10], and CDC’s statement that “[e]-cigarettes have the potential to benefit adults who smoke … if used as a complete substitute for regular cigarettes,” [11] while necessarily preventing access to nicotine products by nonsmoking subpopulations, such as adolescents.

This study’s strengths include use of a large, nationally representative survey with low bias administered by CDC. NHIS results are thought to be generalizable to the entire US population, because that is the purpose of its sample design by CDC’s National Center for Health Statistics [5, 12]. Another strength is the direct measures of stopping smoking (i.e., survey questions answered by adults who actually stopped smoking) as opposed to indirect measures of stopping smoking (e.g., models).

This study also has limitations. First is the inability to parse out individual methods in the “none of the above” category, which is an unavoidable limitation of the NHIS questionnaire design. Because “none of the above” was inferred from respondents who stopped or tried but who did not select any of the surveyed items, the “none of the above” category may be underrepresented in these analyses. Furthermore, the questionnaire did not ask respondents about the duration of treatment use. Future questionnaires should ask respondents for these details. Recall bias may also limit the accuracy of these findings [13].

In conclusion, efforts to reduce smoking among US adults should focus on the subpopulations that stopped smoking the least and encourage use of evidence-based methods.